Gyrodyne (GYRO) Stock Price, News & Analysis

Company Overview

Gyrodyne Company of America, Inc. is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island. This portfolio features a diversified mix of multi-tenant buildings that house outpatient services, rehabilitation centers and specialty laboratories. Gyrodyne’s strategic approach involves acquiring under-utilized or newly developed properties, investing in targeted capital improvements, and securing long-term leases with creditworthy tenants. Through hands-on property management and an emphasis on tenant retention, the firm aims to enhance asset value and maintain a resilient revenue base.

Originally founded in 1959 and initially engaged in rotorcraft design and manufacturing, Gyrodyne transitioned to a real estate-focused business in the late 1980s. Over the decades, the company has built deep ties to the greater Long Island region, leveraging local market knowledge and zoning expertise to support its development initiatives. Led by an experienced management team and overseen by a board of directors with backgrounds in real estate and healthcare industries, Gyrodyne continues to pursue opportunities that align with its mission of delivering high-quality, medically oriented real estate solutions to its tenant community.

Key Stats

• Today's Range: $7.48 to $7.48
• 50-Day Range: $6.89 to $9.10
• 52-Week Range: $6.70 to $12.00
• Volume: 451 shs
• Average Volume: 1,089 shs
• Market Capitalization: $16.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 5/08/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: REAL ESTATE OPS
• Sub-Industry: Diversified REITs
• Current Symbol: NASDAQ:GYRO
• CIK: 1589061
• Web: www.gyrodyne.com
• Phone: (631) 584-5400
• Fax: 631-584-7075
• Employees: 6
• Year Founded: 1946

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,200,000
• Free Float: 1,933,000
• Market Cap: $16.46 million
• Optionable: Not Optionable
• Beta: 0.52